Gene Editing Therapy Stabilizes Neuropathy Scores
- Okay, here's a breakdown of the information provided, extracted from the text:
- * Gene editing therapy (using Nexiguran Ziclumeran) appears to stabilize neuropathy scores in patients with hereditary ATTR polyneuropathy (a rare nerve disease).
- * Study Published In: New England Journal of Medicine * Publication Date: 2025 (likely October, based on the citation) * Authors: julian D.
Okay, here’s a breakdown of the information provided, extracted from the text:
Key Findings/Article Summary:
* Gene editing therapy (using Nexiguran Ziclumeran) appears to stabilize neuropathy scores in patients with hereditary ATTR polyneuropathy (a rare nerve disease).
Source & Publication Details:
* Study Published In: New England Journal of Medicine
* Publication Date: 2025 (likely October, based on the citation)
* Authors: julian D. Gillmore et al.
* DOI: 10.1056/nejmoa2510209 (This is a unique identifier for the research article)
* Website: Science X Network (https://sciencex.com/)
Additional Information:
* Funding/Support: Science X Network is asking for donations to support independent science journalism. Donors recieve an ad-free account.
* copyright: © 2025 Science X Network
* Citation Information: Provided for academic referencing:
* Title: Stabilization of neuropathy scores seen after gene editing therapy for rare nerve disease
* Date Retrieved: 4 october 2025
* Date Published: 4 October 2025
Let me know if you’d like me to focus on a specific aspect of this information or if you have any other questions!